These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 6792738)

  • 1. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    Counts RB; Paskell SL; Elgee SK
    J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
    J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
    Potter EV; Shaughnessy MA; Green D
    Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine Willebrand factor: a population of multimers.
    Fass DN; Knutson GJ; Bowie EJ
    J Lab Clin Med; 1978 Feb; 91(2):307-20. PubMed ID: 413873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there a correlation between sugar content, thrombocyte aggregating activity and molecular size of factor VIII?].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1369-70. PubMed ID: 314662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of porcine and human ristocetin-Willebrand factor.
    Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
    J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.